Lili Fang Selected Research

gastrin-releasing peptide precursor

5/2020

Expression and clinical value of gastrin-releasing peptide precursor in nephropathy and chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lili Fang Research Topics

Disease

2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2018
2	Hyperalgesia 01/2022 - 09/2011
2	Pain (Aches) 01/2022 - 09/2011
2	Ischemic Stroke 11/2020 - 11/2016
2	Stroke (Strokes) 11/2020 - 11/2016
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2020 - 07/2018
2	Lung Diseases (Lung Disease) 01/2020 - 01/2019
2	Vascular Diseases (Vascular Disease) 07/2018 - 11/2016
1	Neuroinflammatory Diseases 01/2022
1	Necrosis 01/2022
1	Chronic Pain 01/2022
1	Invasive Pulmonary Aspergillosis 04/2021
1	Atrial Fibrillation 11/2020
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2020
1	Hemorrhage 11/2020
1	Embolism (Embolus) 11/2020
1	Chronic Renal Insufficiency 05/2020
1	Acute Kidney Injury (Acute Renal Failure) 05/2020
1	Kidney Diseases (Kidney Disease) 05/2020
1	Thyroid Nodule (Nodule, Thyroid) 05/2020
1	Thyroid Neoplasms (Thyroid Cancer) 05/2020
1	Proteinuria 05/2020
1	Pneumonia (Pneumonitis) 07/2018
1	Renal Insufficiency (Renal Failure) 07/2018
1	Neoplasms (Cancer) 07/2018
1	Esophageal Neoplasms (Esophageal Cancer) 07/2018
1	Prostatic Neoplasms (Prostate Cancer) 07/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2018
1	Brain Infarction 11/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2016
1	Infarction (Infarctions) 11/2016
1	Ischemia 10/2015
1	Brain Ischemia (Cerebral Ischemia) 10/2015
1	Wounds and Injuries (Trauma) 10/2015
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2015
1	Neuralgia (Stump Neuralgia) 09/2011

Drug/Important Bio-Agent (IBA)

3	pro-gastrin-releasing peptide (31-98)IBA 05/2020 - 07/2018
2	InterleukinsIBA 01/2022 - 09/2011
2	CytokinesIBA 01/2022 - 11/2016
2	Peptides (Polypeptides)IBA 05/2020 - 05/2020
1	dimethyl itaconateIBA 01/2022
1	Mitogen-Activated Protein Kinase 3IBA 01/2022
1	itaconic acidIBA 01/2022
1	galactomannanIBA 04/2021
1	Warfarin (Coumadin)FDA LinkGeneric 11/2020
1	AnticoagulantsIBA 11/2020
1	N(4)-oleylcytosine arabinosideIBA 11/2020
1	Vitamin K FDA Link 11/2020
1	Tumor Biomarkers (Tumor Markers)IBA 05/2020
1	gastrin-releasing peptide precursorIBA 05/2020
1	Carcinoembryonic AntigenIBA 05/2020
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 05/2020
1	GlucosidasesIBA 05/2020
1	AlbuminsIBA 05/2020
1	Biomarkers (Surrogate Marker)IBA 05/2020
1	big gastrinIBA 05/2020
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	triphenyltetrazoliumIBA 11/2016
1	Streptozocin (Streptozotocin)FDA Link 10/2015
1	Glucose (Dextrose)FDA LinkGeneric 10/2015
1	Pyruvaldehyde (Methylglyoxal)IBA 10/2015
1	Chloroquine (Aralen)FDA LinkGeneric 10/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2011
1	AcetoneIBA 09/2011

Therapy/Procedure

1	Patient Care Bundles 01/2022
1	Anesthesia 01/2022
1	General Anesthesia 01/2022
1	Intraperitoneal Injections 01/2022
1	Length of Stay 01/2022
1	Ligation 01/2022
1	Drug Therapy (Chemotherapy) 11/2016
1	Hyperbaric Oxygenation 09/2011
1	Therapeutics 09/2011